Cosmetics DTC brand due diligence

Once a cosmetics brand deal is under letter of intent, diligence turns every compliance and formulation question raised earlier in the process into an actual document trail. Each item either closes out cleanly on its own, or it needs a negotiated remedy — a price adjustment, an escrow holdback, or a condition to closing — before the deal can proceed, and knowing which is which is most of the work.

The document set specific to this sub-sector

Beyond the standard financial and corporate records, a cosmetics acquisition needs the Cosmetic Notification Form status for every active formulation, a documented cross-check of every ingredient list against Health Canada’s Cosmetic Ingredient Hotlist, the contract-manufacturer agreement and any formulation or recipe documentation behind it, proof of bilingual labelling and, where sales reach Quebec, evidence the packaging actually meets the Charter’s French-language standard, and an inventory ageing schedule tied to each product’s shelf-life or period-after-opening date.

Registry and public-record checks worth running

Run a trademark search through the Canadian Intellectual Property Office to confirm the brand name and logo are actually registered, currently held by the seller’s corporate entity, and not sitting in a founder’s personal name or a dissolved related company. There is no equivalent public, searchable registry for cosmetic notifications the way there is for a trademark, so the notification record has to come directly from the seller and be independently corroborated — through the contract manufacturer, through Health Canada correspondence, or both — rather than taken on the seller’s word alone.

Corroborate what the contract manufacturer actually says

A buyer’s diligence should include direct contact with the contract manufacturer, not just a copy of the agreement, because the manufacturer’s own willingness to continue supplying — and on what terms — is exactly the kind of thing a seller has an incentive to describe optimistically. Ask the manufacturer directly whether they intend to keep producing for the business after a change of ownership, whether pricing or minimum-order terms would change, and whether they will confirm in writing that they hold, and will disclose, the full formulation needed to refile each notification.

The findings that actually kill a cosmetics deal

A restricted or Hotlist-adjacent ingredient turning up in a formulation still being actively sold is the single most serious finding, because it exposes the buyer to a compliance action the moment they take over. A contract manufacturer who declines to keep supplying the buyer, or who will not disclose the full formulation needed to refile the notification, is close behind it, since it threatens the product’s continuity regardless of how clean everything else looks. Labelling that is materially non-compliant and cannot be economically corrected before the buyer needs to keep selling belongs in the same category.

What a finding actually means once it surfaces

Not every finding is equally serious, and treating them all the same way is a mistake in either direction. A single SKU with a lapsed notification is usually remediable — refile it, price the interim risk into the deal, and move on. A contract-manufacturer relationship that will not survive the change of ownership is a different order of problem entirely, because it threatens the supply of the whole catalogue, not one product line, and no price adjustment fixes a manufacturer who simply will not ship to the new owner.

Verifying inventory dating is a physical exercise, not a spreadsheet one

A seller’s inventory schedule is a starting point, not the final word — a buyer’s diligence should include an actual physical count against batch and lot numbers, cross-checked to each product’s labelled shelf-life or period-after-opening date, rather than relying on the balance sheet figure the seller provides. Discrepancies between the reported inventory value and what a physical count and date check actually turns up are common enough that a buyer’s accountant should treat this as a standard step, not an optional one, and any material gap belongs in the purchase price discussion rather than being absorbed quietly after closing.

Check the paper trail behind contractors, not just employees

Small cosmetics brands frequently rely on freelance formulators, package designers or copywriters rather than full-time staff, and any of that work can carry the same intellectual-property gap a digital business faces if there is no signed assignment on file. Confirm who actually holds the rights to the brand’s packaging design, product photography and any proprietary formulation notes contributed by an outside consultant, because a gap here is a genuine ownership defect on the brand’s core assets, not a minor employment-file omission.

Where concentration risk shows up outside the regulatory items

A brand that draws a large share of its revenue from one retail account or one influencer partnership carries a concentration risk that has nothing to do with formulation compliance, and it needs its own line of diligence: the actual contract terms behind that relationship, how it renews, and what happens to the brand’s revenue if that one account or that one partner walks away after the sale closes.